NU SKIN ENTERPRISES, INC. (NUS) Form 8-K — Aug 21, 2026
Nu Skin Enterprises disclosed in an 8-K that Justin Keisel, Executive Vice President and President of Global Sales, began a medical leave of absence effective August 17, 2026. Chayce Clark, the company's Executive Vice President, Chief Operating Officer and Chief Legal Officer, will lead Keisel's organization during his time away.
Price after filing
1 day: 0.0%7 days: +2.3%30 days: -3.4%
Close on the filing date to close N calendar days later (from $4.74). Historical, not a forecast.
AI analysis
Red flags1 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.